Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 04 March, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of JHS Svendgaard Laboratories Ltd

About the Company - JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd. is a Public Limited Listed company incorporated on 08/10/2004 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L74110HP2004PLC027558 and registration number is 027558. Currently company belongs to the Industry of Personal Care. Company’s Total Operating Revenue is Rs. 79.91 Cr. and Equity Capital is Rs. 64.90 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Personal CareTrilokpur Road, Kheri (Kala Amb), Sirmour Dist. Himachal Pradesh 173030cs@svendgaard.com
http://www.svendgaard.com
Management
NamePosition Held
Mr. Rajagopal Chakravarthi VenkateishChairman & Ind.Director
Mr. Nikhil NandaManaging Director
Mr. Mukul PathakIndependent Director
Mrs. Rohina Sanjay SangtaniIndependent Director
Mr. Kapil MinochaIndependent Director
Mr. Vinay MittalNon Exe.Non Ind.Director

JHS Svendgaard Laboratories Ltd. Share Price Update

Share PriceValue
Today₹29.45
Previous Day₹30.99

Basic Stock Data of JHS Svendgaard Laboratories Ltd

Market Cap 194 Cr.
Current Price 24.8
High / Low39.5/13.1
Stock P/E39.9
Book Value 21.8
Dividend Yield0.00 %
ROCE1.08 %
ROE0.95 %
Face Value 10.0

Data Source: screener.in

JHS Svendgaard Laboratories Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales31.6726.9425.3821.5924.6420.9119.1121.3121.0525.4525.4015.9018.93
Expenses28.7225.1225.3322.2923.5022.0519.2522.7723.0227.2828.2518.0218.52
Operating Profit2.951.820.05-0.701.14-1.14-0.14-1.46-1.97-1.83-2.85-2.120.41
OPM %9.31%6.76%0.20%-3.24%4.63%-5.45%-0.73%-6.85%-9.36%-7.19%-11.22%-13.33%2.17%
Other Income0.440.764.392.581.692.742.381.482.521.67-10.820.410.20
Interest0.300.300.310.240.270.270.610.680.120.250.390.130.10
Depreciation1.901.841.621.791.861.711.691.701.491.712.311.321.50
Profit before tax1.190.442.51-0.150.70-0.38-0.06-2.36-1.06-2.12-16.37-3.16-0.99
Tax %26.05%75.00%-13.15%-80.00%34.29%92.11%-7,300.00%-75.85%13.21%1.89%38.12%18.35%26.26%
Net Profit0.890.112.85-0.290.47-0.02-4.44-4.16-0.92-2.08-10.12-2.59-0.73
EPS in Rs0.160.020.41-0.040.040.04-0.67-0.59-0.14-0.24-1.52-0.40-0.11

JHS Svendgaard Laboratories Ltd Quarterly Chart

JHS Svendgaard Laboratories Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales127603555100104140124139101869675
Expenses1104839599392126124137998710579
Operating Profit1612-4-471214022-1-9-5
OPM %13%20%-11%-7%7%11%10%0%1%2%-1%-9%-6%
Other Income112-3-6-170326379-4-8
Interest610140011121111
Depreciation71415121067797777
Profit before tax30-35-22-22538-2-610-22-20
Tax %66%1,357%18%-0%0%-327%32%19%17%-39%4,000%23%
Net Profit1-4-29-22-222226-2-51-4-17-13
EPS in Rs0.63-1.56-11.95-9.20-5.764.984.29-0.11-0.330.19-0.62-2.38-2.01
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

JHS Svendgaard Laboratories Ltd Profit & Loss Yearly Chart

JHS Svendgaard Laboratories Ltd Growth

Compounded Sales Growth
10 Years:5%
5 Years:-7%
3 Years:-12%
TTM:4%
Compounded Profit Growth
10 Years:8%
5 Years:-26%
3 Years:2%
TTM:136%
Stock Price CAGR
10 Years:16%
5 Years:5%
3 Years:3%
1 Year:79%
Return on Equity
10 Years:-1%
5 Years:0%
3 Years:0%
Last Year:1%

JHS Svendgaard Laboratories Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital18242424384461616164656578
Reserves97653896578611311611712412110892
Borrowings671015419322797632
Other Liabilities52417433252332395533306024
Total Liabilities233232190171122155208223241228222236197
Fixed Assets52135121108656571716663596669
CWIP240001115792095
Investments000001181062443
Other Assets1579770635789118137163154140157120
Total Assets233232190171122155208223241228222236197

JHS Svendgaard Laboratories Ltd Reserves and Borrowings Chart

JHS Svendgaard Laboratories Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity -1260287-4-414-111012-919
Cash from Investing Activity -26-22311-3-27-7-11-2-56
Cash from Financing Activity 37-39-29-104101413010-28
Net Cash Flow-1-22-1230-5-020-1633

JHS Svendgaard Laboratories Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days29522018816725481111582522137778
Inventory Days5413212294539565603097114117
Days Payable1804079510667123153134177128130183
Cash Conversion Cycle170-55215156121923851051826113
Working Capital Days20129-36884595612218720227722247
ROCE %6%1%-10%-12%-3%5%8%-0%4%1%1%-1%

JHS Svendgaard Laboratories Ltd Financial Efficiency Indicators Chart

JHS Svendgaard Laboratories Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters41.77%41.77%41.77%41.77%42.23%42.23%42.23%42.23%42.23%42.23%37.73%37.73%
FIIs0.47%0.39%0.00%0.04%0.18%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%9.16%
Public57.77%57.84%58.23%58.20%57.59%57.77%57.77%57.78%57.78%57.78%62.25%53.10%
No. of Shareholders20,01821,81725,37325,15524,75424,31724,30524,30823,96523,80022,79422,648

JHS Svendgaard Laboratories Ltd Shareholding Pattern Chart

No. of JHS Svendgaard Laboratories Ltd Shareholders

This stock is not held by any mutual fund

JHS Svendgaard Laboratories Ltd ROCE Trend

JHS Svendgaard Laboratories Ltd EPS Trend

JHS Svendgaard Laboratories Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)-2.34-0.630.20-0.32-0.11
Diluted EPS (Rs.)-2.34-0.630.20-0.32-0.11
Cash EPS (Rs.)-1.430.421.330.640.89
Book Value[Excl.RevalReserv]/Share (Rs.)27.7830.0530.7430.3129.66
Book Value[Incl.RevalReserv]/Share (Rs.)27.7830.0530.7430.3129.66
Revenue From Operations / Share (Rs.)14.8213.2915.6522.8420.38
PBDIT / Share (Rs.)0.811.321.472.550.99
PBIT / Share (Rs.)-0.330.230.341.11-0.16
PBT / Share (Rs.)-3.370.010.15-0.95-0.33
Net Profit / Share (Rs.)-2.58-0.660.20-0.79-0.27
NP After MI And SOA / Share (Rs.)-2.38-0.620.18-0.32-0.11
PBDIT Margin (%)5.509.919.3911.144.89
PBIT Margin (%)-2.251.732.194.84-0.81
PBT Margin (%)-22.700.110.96-4.20-1.64
Net Profit Margin (%)-17.43-4.971.33-3.48-1.34
NP After MI And SOA Margin (%)-16.07-4.691.18-1.42-0.54
Return on Networth / Equity (%)-8.96-2.170.63-1.11-0.38
Return on Capital Employeed (%)-1.090.731.073.50-0.55
Return On Assets (%)-6.54-1.820.52-0.82-0.30
Total Debt / Equity (X)0.000.000.000.000.03
Asset Turnover Ratio (%)0.410.360.420.590.56
Current Ratio (X)2.364.185.232.692.63
Quick Ratio (X)2.003.544.732.572.39
Inventory Turnover Ratio (X)4.365.168.9415.689.80
Interest Coverage Ratio (X)5.096.137.637.945.88
Interest Coverage Ratio (Post Tax) (X)2.78-2.082.083.96-0.61
Enterprise Value (Cr.)70.51136.74117.0751.74176.62
EV / Net Operating Revenue (X)0.731.591.160.371.42
EV / EBITDA (X)13.3115.9912.373.3429.07
MarketCap / Net Operating Revenue (X)1.061.551.270.321.35
Price / BV (X)0.590.710.680.250.95
Price / Net Operating Revenue (X)1.061.551.270.321.35
EarningsYield-0.15-0.030.01-0.040.00

JHS Svendgaard Laboratories Ltd Profitability Ratios (%)

JHS Svendgaard Laboratories Ltd Liquidity Ratios

JHS Svendgaard Laboratories Ltd Liquidity Ratios (%)

JHS Svendgaard Laboratories Ltd Interest Coverage Ratios (%)

JHS Svendgaard Laboratories Ltd Valuation Ratios

Fair Value of JHS Svendgaard Laboratories Ltd Stock

Fair Value: ₹8.43

The stock is overvalued by 66.01% compared to the current price ₹24.8

*Investments are subject to market risks

Strength and Weakness of JHS Svendgaard Laboratories Ltd Stock

StrengthWeakness
  1. The company has higher reserves (94.62 cr) compared to borrowings (21.69 cr), indicating strong financial stability.
  1. The stock has a low average ROCE of 0.00%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 93.17, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 82.17, which may not be favorable.
  4. The company has not shown consistent growth in sales (95.54) and profit (-6.31).

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in JHS Svendgaard Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE